Prostate Cancer with Bone Metastasis
Links shared publicly online about this topic.
- 651total visits
Prostate Cancer with Bone Metastasis
View full resource at hcplive.com
Tags: Cancer, Bone Cancer, Bone Metastasis, Prostate Cancer, Bone, Prostate, Men's Health
Most Recently Shared on December 16, 2010 at 2:07 pm By:
Prostate Cancer with Bone Metastasis Watch the video! http://www.hcplive.com/videos/Prostate-Cancer-with-Bone-Metastasis
Choosing Wisely: 5 Things Physicians and Patients Should Question http://t.co/y2UEToCi via @ASCO
choosingwisely.org — “Choosing Wisely: 5 Things Physicians and Patients Should Question http://t.co/y2UEToCi via @ASCO” View full resource at choosingwisely.org
Most Recently Shared on April 5, 2012 at 3:52 pm By:
Robert S. Miller, MD Doctor, Internist, Oncologist, and Physician
Choosing Wisely: 5 Things Physicians and Patients Should Question http://t.co/y2UEToCi via @ASCO
Halting The Spread Of A Deadly Childhood Bone Cancer
medicalnewstoday.com — “Many children with the bone cancer, osteosarcoma, die after the tumor spreads to their lungs. In a critical step toward finding a way to stop metastasis, researchers at Georgetown Lombardi Compreh” View full resource at medicalnewstoday.com
Most Recently Shared on April 5, 2012 at 7:05 am By:
MNT Pediatrics News Pediatrics and Health News
Halting The Spread Of A Deadly Childhood Bone Cancer http://t.co/bbBMsARa #pediatrics
Molecular Cancer | Abstract | c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis
molecular-cancer.com — “The c-Myb transcription factor is essential for the maintenance of stem-progenitor cells in bone marrow, colon epithelia, and neurogenic niches. c-Myb malfunction contributes to several types of malignancies including breast cancer. However, the function of c-Myb in the metastatic spread of breast tumors remains unexplored. In this study, we report a novel role of c-Myb in the control of specific proteases that regulate the matrix-dependent invasion of breast cancer cells.” View full resource at molecular-cancer.com
Most Recently Shared on March 24, 2012 at 1:16 pm By:
c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer ... http://t.co/mwz1IUbm
The distribution of bone mets in men with advanced prostate cancer « THE "NEW" PROSTATE CANCER INFOLINK
prostatecancerinfolink.net — “The distribution of bone mets in men with advanced prostate cancer « THE "NEW" PROSTATE CANCER INFOLINK” View full resource at prostatecancerinfolink.net
Most Recently Shared on March 17, 2012 at 10:33 am By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
The distribution of bone mets in men with advanced prostate cancer: Those who are used to seeing the bone scans ... http://t.co/eRzdejQy
Elsevier
thebonejournal.com — “Elsevier” View full resource at thebonejournal.com
Most Recently Shared on March 15, 2012 at 4:40 am By:
The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis: ... http://t.co/US4qgZ1Z
ODAC rejects expanded use for bone drug in men with prostate cancer | HemOncToday
hemonctoday.com — “The FDA’s Oncologic Drugs Advisory Committee rejected a request from Amgen to allow denosumab to be used as a preventive measure for men w” View full resource at hemonctoday.com
Most Recently Shared on February 9, 2012 at 1:11 pm By:
HemOnc Today Oncology and Health News
ODAC rejects expanded use for bone drug in men with prostate cancer: http://t.co/eFDclp28
FDA Panel Votes Against Expanding Use of Amgen Drug Xgeva - WSJ.com
online.wsj.com — “A federal advisory panel rejected a proposal by Amgen to expand the use of its bone drug Xgeva in men with prostate cancer that has not spread to the bones.” View full resource at online.wsj.com
Most Recently Shared on February 9, 2012 at 4:05 am By:
FDA Panel Votes Against Expanding Use of Amgen Drug Xgeva: A federal advisory panel rejected a proposal by Amgen... http://t.co/INM0YSIz
FDA panel votes against wider use of Amgen drug | Reuters
reuters.com — “WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance” View full resource at reuters.com
Most Recently Shared on February 9, 2012 at 4:05 am By:
FDA panel votes against wider use of Amgen drug: WASHINGTON (Reuters) - An advisory panel on Wednesday recommend... http://t.co/W9qkRVJr
FDA questions Amgen drug for prostate cancer - USATODAY.com
yourlife.usatoday.com — “The FDA will ask a panel of outside experts whether the benefits of Amgen's Xgeva outweigh its risks, which included bone disease.” View full resource at yourlife.usatoday.com
Most Recently Shared on February 8, 2012 at 4:27 am By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
FDA questions Amgen drug for prostate cancer: The FDA will ask a panel of outside experts whether the benefits o... http://t.co/trknJg2W
Wayne State Research To Shed Light On Bone Metastasis In Prostate Cancer « CBS Detroit
detroit.cbslocal.com — “Prostate cancer is the most frequent and second deadliest cancer men face. A team of Wayne State University researchers recently received $363,660 from the National Cancer Institute of the National Institutes of Health for a project that aims to learn more about the deadly spread of prostate cancer into the bones. News, Sports, Weather, Traffic and the Best of Detroit. CBSDetroit.com” View full resource at detroit.cbslocal.com
Most Recently Shared on January 22, 2012 at 9:39 pm By:
Wayne State Research To Shed Light On Bone Metastasis In Prostate Cancer: Prostate cancer is the most frequent a... http://t.co/2we0aG8W
NCI-funded project aims to shed new light on implications for bone metastasis in prostate cancer
news-medical.net — “Prostate cancer is the most frequent and second deadliest cancer men face. A team of Wayne State University researchers recently received $363,660 from the National Cancer Institute of the National Institutes of Health for the project - "Bone-induced c-kit in prostate cancer cells: implications for bone metastasis" - that aims to shed new light on implications for bone metastasis in prostate cancer.” View full resource at news-medical.net
Most Recently Shared on January 21, 2012 at 6:03 am By:
NCI-funded project aims to shed new light on implications for bone metastasis in prostate cancer: Prostate cance... http://t.co/Sj3NZ6o3
The Cancer Chronicles ~ PSA, Scans, Metastasis, Miracles... Oh, My! | Dr. Mom Online
drmomonline.com — “The journey with dad's metastatic prostate cancer and his visits to the cancer clinic continues... and continues to cause head scratching!” View full resource at drmomonline.com
Most Recently Shared on January 20, 2012 at 3:30 pm By:
Dr.ColleenTrombley Doctor, CAM, and Chiropractor
The Cancer Chronicles ~ PSA, Scans, Metastasis, Miracles… Oh, My! http://t.co/9glHsYTo
prostate cancer metastasized to bone -- low PSA and no pain | Cancer Survivors Network
csn.cancer.org — “prostate cancer metastasized to bone -- low PSA and no pain | Cancer Survivors Network” View full resource at csn.cancer.org
Most Recently Shared on December 20, 2011 at 10:38 pm By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
prostate cancer metastasized to bone -- low PSA and no pain: My husband was initially diagnosed with PCa in 1999... http://t.co/xboBDV1l
This Week in The People's Pharmacy - The People's Pharmacy®
peoplespharmacy.com — “This Week in The People's Pharmacy - The People's Pharmacy®” View full resource at peoplespharmacy.com
Most Recently Shared on December 5, 2011 at 11:25 pm By:
The Peoples Pharmacy Health Site
This Week in The People's Pharmacy - Listen To Our Podcast: 837 Prostate Cancer PuzzleFighting Bone Loss with YogaSa... http://t.co/0yDTyaZt
Denosumab and Bone-Metastasis-Free Survival In Men With Castration-Resistant Prostate Cancer: Results of a Phase 3, Randomised, Placebo-Controlled Trial - OncologySTAT
oncologystat.com — “Lancet. 2011 Nov 15;[Epub Ahead of Print] - MR Smith, F Saad, R Coleman, N Shore, C Goessl, et al” View full resource at oncologystat.com
Most Recently Shared on December 1, 2011 at 5:29 pm By:
OncologySTAT Oncology and Health Site
Story of the Week: Denosumab and Bone–Metastasis-Free Survival In Advanced Prostate Cancer http://t.co/SvZu9qdW
Advertisement
